Skip to main content
. 2021 May 23;11(6):787. doi: 10.3390/biom11060787

Figure 1.

Figure 1

Flowchart for drug pipeline for attacking COVID-19 via a polypharma small-molecule approach using in silico screening and advanced simulation biasing. (A) Biological infection of SARS-CoV-2 from initial binding, entry and replication to virus proliferation. (B) Overview of COVID-19 Drug Discovery Pipeline.